Sanara MedTech (SMTI) Equity Average (2011 - 2026)

Sanara MedTech has reported Equity Average for 13 years, with the latest figure at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 82.85% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (down 82.85% YoY), and the FY2025 full-year result was $22.4 million, down 46.3% from the prior year.
• Equity Average for Q1 2026 stood at $6.5 million, up from $6.0 million in the prior quarter.
• The five-year high for Equity Average was $44.3 million in Q4 2023, with the low at $6.0 million in Q4 2025.
• Historically, Equity Average has averaged $34.8 million across 5 years, with a median of $40.4 million in 2024.
• Annual changes were most pronounced in 2022 — Equity Average surged 42.01% — and 2025, when it tumbled 84.59%.
• Sanara MedTech's Equity Average stood at $43.2 million in 2022, then grew by 2.68% to $44.3 million in 2023, then slipped by 11.64% to $39.2 million in 2024, then plunged by 84.59% to $6.0 million in 2025, then increased by 7.28% to $6.5 million in 2026.
• The last three Equity Average figures came in at $6.5 million (Q1 2026), $6.0 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.